Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures. 2016

M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
Department of Environmental Biology and Education, Gyula Juhász Faculty of Education, Institute of Applied Science, University of Szeged, Szeged, Hungary.

The effects of ghrelin on vasopressin and oxytocin secretion were studied in 13-14-day cell cultures of isolated rat neurohypophyseal tissue. The vasopressin and oxytocin contents of the supernatant were determined by radioimmunoassay after a 1- or 2-h incubation. Significantly increased levels of vasopressin and oxytocin production were detected in the cell culture media following ghrelin administration, depending on the ghrelin doses. The oxytocin level proved to be more elevated than that of vasopressin. The increase of vasopressin and oxytocin secretion could be totally blocked by previous administration of the ghrelin receptor antagonist ([D-Lys3]-growth hormone-releasing peptide-6). Application of the ghrelin receptor antagonist after ghrelin administration proved ineffective. The results indicate that vasopressin and oxytocin release is influenced directly by the ghrelin system, and the effects of ghrelin on vasopressin and oxytocin secretion from the neurohypophyseal tissue in rats can occur at the level of the posterior pituitary. Our observations lend support to the view that neurohypophysis contains ghrelin receptors.

UI MeSH Term Description Entries
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005089 Exocytosis Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014667 Vasopressins Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure. Antidiuretic Hormone,Antidiuretic Hormones,beta-Hypophamine,Pitressin,Vasopressin,Vasopressin (USP),Hormone, Antidiuretic,beta Hypophamine

Related Publications

M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
November 2003, Regulatory peptides,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
December 2002, Regulatory peptides,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
January 1986, Neuroendocrinology,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
January 1998, Rapid communications in mass spectrometry : RCM,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
April 2001, Regulatory peptides,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
December 2002, European journal of endocrinology,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
January 2018, Endocrine, metabolic & immune disorders drug targets,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
January 1984, Psychoneuroendocrinology,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
August 1986, Biological chemistry Hoppe-Seyler,
M Gálfi, and M Radács, and Zs Molnár, and I Budai, and G Tóth, and A Pósa, and K Kupai, and Z Szalai, and R Szabó, and H A Molnár, and J Gardi, and Ferenc A László, and Cs Varga
January 1990, Peptides,
Copied contents to your clipboard!